$7.73
-0.69-8.19%
At Close: -
$7.71
-0.02-0.26%
After Hours: 4:31 PM EDT
15 minutes delayed
Rigel Pharmaceuticals
RIGLNASDAQ
Rigel Pharmaceuticals (NASDAQ:RIGL) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 01/08/2024 | RIGL | Rigel Pharmaceuticals | Q4 | 2023 | — | — | — | $35.70M | $35.70M | $29.78M | Get Alert |
| 01/09/2023 | RIGL | Rigel Pharmaceuticals | Q4 | 2022 | — | — | — | $51.30M | $51.30M | $21.65M | Get Alert |
| 01/10/2022 | RIGL | Rigel Pharmaceuticals | Q4 | 2021 | — | — | — | $20.40M | $20.40M | $23.39M | Get Alert |
| 01/11/2021 | RIGL | Rigel Pharmaceuticals | Q4 | 2020 | — | — | — | $18.40M | $18.40M | $17.81M | Get Alert |
| 01/13/2020 | RIGL | Rigel Pharmaceuticals | Q4 | 2019 | — | — | — | $15.40M | $15.40M | $15.14M | Get Alert |
FAQ
What is the most recent guidance for Rigel Pharmaceuticals (RIGL)?
There have been no specific sales or earnings guidance reported for Rigel Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.